Skip to content

Author

C. Angelini

We have 1 of 108 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Therapeutic Advances and Novel Drug Treatment Opportunities in the Neuromuscular Disorders Area

This Editorial examines how the emergence of new therapies impacts the survival and motility of children and adults with spinal muscular atrophy and Duchenne or Becker muscular dystrophy, limb girdle muscular dystrophy, late-onset glycogenosis type 2, myotonic dystrophy and facioscapulohumeral dystrophy.

C. Angelini · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.